Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Gina Kruse

Concepts (245)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Smoking Cessation
18
2025
434
6.760
 Why?
Early Detection of Cancer
9
2026
452
2.810
 Why?
Text Messaging
5
2023
174
2.280
 Why?
Tobacco Use
4
2026
64
1.950
 Why?
Tobacco Use Cessation
3
2025
28
1.810
 Why?
Smoking
9
2026
1556
1.780
 Why?
Electronic Nicotine Delivery Systems
7
2026
109
1.300
 Why?
Primary Health Care
7
2023
1757
1.250
 Why?
Massachusetts
9
2026
181
1.200
 Why?
HIV Infections
9
2026
3048
1.090
 Why?
Smokers
4
2020
148
1.010
 Why?
Varenicline
2
2025
28
0.970
 Why?
Tobacco Products
3
2025
89
0.960
 Why?
Uterine Cervical Neoplasms
3
2025
275
0.960
 Why?
Colorectal Neoplasms
4
2025
848
0.940
 Why?
Behavior Therapy
3
2025
286
0.930
 Why?
Tobacco Use Disorder
3
2022
223
0.920
 Why?
Opioid-Related Disorders
4
2026
581
0.910
 Why?
Intention
1
2026
183
0.830
 Why?
Peer Group
1
2026
250
0.810
 Why?
Postal Service
2
2020
27
0.800
 Why?
Buprenorphine
2
2025
182
0.800
 Why?
Laboratories
1
2023
111
0.720
 Why?
Lung Neoplasms
2
2026
2636
0.720
 Why?
Community Health Services
2
2015
232
0.720
 Why?
Social Support
1
2026
643
0.700
 Why?
United States Indian Health Service
2
2022
46
0.670
 Why?
India
4
2026
216
0.660
 Why?
Humans
66
2026
143817
0.650
 Why?
Patient Discharge
3
2024
939
0.640
 Why?
Health Knowledge, Attitudes, Practice
3
2026
1402
0.640
 Why?
Mentoring
1
2023
162
0.620
 Why?
Middle Aged
28
2026
35629
0.600
 Why?
Electronic Health Records
4
2016
1170
0.600
 Why?
Alaska Natives
1
2022
155
0.590
 Why?
Adult
33
2026
40128
0.580
 Why?
Cross-Sectional Studies
13
2026
5761
0.570
 Why?
Papillomavirus Infections
1
2023
354
0.560
 Why?
Health Behavior
3
2022
794
0.550
 Why?
Female
41
2026
77569
0.550
 Why?
Delivery of Health Care
4
2023
946
0.540
 Why?
Community Health Centers
5
2025
59
0.540
 Why?
Male
36
2026
71568
0.530
 Why?
Pilot Projects
6
2025
1851
0.520
 Why?
Telemedicine
3
2025
940
0.520
 Why?
Hospitalization
4
2025
2340
0.520
 Why?
Meaningful Use
1
2016
13
0.490
 Why?
Rural Population
3
2024
638
0.490
 Why?
Indians, North American
1
2022
660
0.470
 Why?
Commerce
2
2026
77
0.460
 Why?
Comorbidity
2
2017
1638
0.450
 Why?
Motivation
2
2019
607
0.440
 Why?
Smoke-Free Policy
1
2014
13
0.430
 Why?
Smoking Prevention
1
2015
170
0.420
 Why?
Unnecessary Procedures
1
2014
53
0.420
 Why?
Opiate Substitution Treatment
3
2025
173
0.400
 Why?
Tobacco Smoking
2
2024
25
0.400
 Why?
Reimbursement, Incentive
1
2013
41
0.390
 Why?
Program Development
1
2015
368
0.390
 Why?
Counseling
4
2024
400
0.380
 Why?
Vaping
2
2025
66
0.380
 Why?
United States
13
2026
15602
0.380
 Why?
Tobacco Smoke Pollution
1
2014
236
0.360
 Why?
Colonoscopy
1
2014
255
0.360
 Why?
Health Equity
3
2024
119
0.350
 Why?
Documentation
1
2013
196
0.340
 Why?
Telephone
2
2023
175
0.340
 Why?
Population Surveillance
1
2014
491
0.340
 Why?
Aged
15
2026
25616
0.330
 Why?
Neoplasms
2
2023
2902
0.320
 Why?
Prevalence
5
2026
2819
0.300
 Why?
Boston
4
2026
93
0.290
 Why?
Anti-HIV Agents
2
2014
864
0.290
 Why?
Alcoholism
2
2025
814
0.280
 Why?
Qualitative Research
4
2026
1626
0.280
 Why?
Referral and Consultation
2
2012
839
0.270
 Why?
Randomized Controlled Trials as Topic
3
2025
1688
0.270
 Why?
Tobacco, Smokeless
1
2026
13
0.240
 Why?
Students
2
2022
667
0.240
 Why?
Oklahoma
1
2026
19
0.240
 Why?
Cotinine
1
2026
78
0.230
 Why?
Flavoring Agents
1
2025
13
0.230
 Why?
Alcohol Deterrents
1
2025
26
0.230
 Why?
South Africa
2
2024
221
0.230
 Why?
Appointments and Schedules
2
2002
98
0.220
 Why?
Feasibility Studies
2
2022
1065
0.220
 Why?
Faculty
2
2022
149
0.210
 Why?
Pandemics
3
2021
1675
0.210
 Why?
Occult Blood
1
2024
39
0.210
 Why?
Outpatients
2
2024
431
0.200
 Why?
Patient Compliance
2
2012
612
0.200
 Why?
Substance Withdrawal Syndrome
1
2025
183
0.200
 Why?
Mental Disorders
2
2002
1127
0.190
 Why?
Social Determinants of Health
2
2024
294
0.190
 Why?
Cost-Benefit Analysis
1
2025
616
0.190
 Why?
Health Policy
1
2026
390
0.190
 Why?
Vaginal Smears
1
2023
56
0.190
 Why?
Narcotic Antagonists
1
2025
205
0.190
 Why?
Safety-net Providers
1
2024
126
0.190
 Why?
Cooperative Behavior
1
2025
460
0.180
 Why?
Papillomaviridae
1
2023
121
0.180
 Why?
Outpatient Clinics, Hospital
1
2002
80
0.180
 Why?
Interrupted Time Series Analysis
1
2022
72
0.180
 Why?
Treatment Refusal
1
2002
94
0.180
 Why?
Medically Underserved Area
1
2022
99
0.180
 Why?
Student Run Clinic
1
2021
3
0.170
 Why?
Mass Screening
3
2025
1325
0.170
 Why?
Tuberculosis
1
2024
287
0.170
 Why?
Internet
1
2026
699
0.170
 Why?
Patient Participation
1
2005
436
0.170
 Why?
Pain Management
1
2005
399
0.170
 Why?
Medication Adherence
1
2025
519
0.160
 Why?
Developing Countries
2
2015
313
0.160
 Why?
Education, Medical, Undergraduate
1
2023
205
0.160
 Why?
Community Networks
1
2020
57
0.150
 Why?
Physician-Patient Relations
1
2005
585
0.150
 Why?
Longitudinal Studies
2
2020
2947
0.150
 Why?
Ambulatory Care
1
2024
592
0.150
 Why?
Education, Medical
1
2023
270
0.150
 Why?
Crisis Intervention
1
2019
31
0.150
 Why?
Interviews as Topic
3
2019
884
0.150
 Why?
Young Adult
7
2025
13914
0.150
 Why?
Pain
1
2005
776
0.150
 Why?
Preventive Health Services
1
2020
152
0.140
 Why?
Analgesics, Opioid
2
2024
1135
0.140
 Why?
Nevirapine
2
2008
18
0.140
 Why?
Cohort Studies
5
2025
5862
0.140
 Why?
Students, Medical
1
2023
375
0.130
 Why?
Organophosphonates
2
2008
96
0.130
 Why?
Decision Making
1
2005
966
0.130
 Why?
Surveys and Questionnaires
4
2019
6004
0.130
 Why?
Liver Transplantation
1
2024
781
0.130
 Why?
Deoxycytidine
2
2008
218
0.120
 Why?
Adolescent
8
2025
22233
0.120
 Why?
Licensure
2
2026
16
0.120
 Why?
Communication
1
2023
959
0.120
 Why?
Infectious Disease Transmission, Vertical
2
2008
185
0.120
 Why?
Pneumonia, Viral
1
2021
385
0.120
 Why?
Texas
4
2005
277
0.120
 Why?
Hypertension
1
2024
1239
0.120
 Why?
Diabetes Mellitus
1
2024
1088
0.120
 Why?
Diffusion of Innovation
1
2016
99
0.120
 Why?
Adenine
2
2008
333
0.110
 Why?
Focus Groups
2
2022
573
0.110
 Why?
Tomography, X-Ray Computed
1
2026
2782
0.110
 Why?
Caregivers
1
2024
1025
0.110
 Why?
Allied Health Personnel
1
2015
55
0.110
 Why?
Health Surveys
1
2017
509
0.110
 Why?
Automobiles
1
2014
18
0.110
 Why?
Logistic Models
3
2017
2095
0.110
 Why?
Uganda
1
2014
89
0.110
 Why?
Community Health Workers
1
2015
85
0.100
 Why?
Colonic Polyps
1
2014
83
0.100
 Why?
Odds Ratio
3
2008
1057
0.100
 Why?
Program Evaluation
2
2020
947
0.100
 Why?
Residence Characteristics
2
2014
376
0.100
 Why?
Managed Care Programs
1
2013
135
0.090
 Why?
Research Design
1
2019
1121
0.090
 Why?
Patient Admission
1
2014
206
0.090
 Why?
Hospitals, Psychiatric
2
2002
26
0.090
 Why?
Stress, Psychological
1
2021
1147
0.090
 Why?
Social Class
1
2014
270
0.090
 Why?
Nurses
1
2014
179
0.090
 Why?
Prospective Studies
3
2025
7900
0.090
 Why?
HIV-1
2
2008
904
0.090
 Why?
Patient Acceptance of Health Care
3
2022
872
0.090
 Why?
Health Services Accessibility
4
2024
1078
0.090
 Why?
Feedback
1
2012
182
0.090
 Why?
Health Plan Implementation
1
2012
140
0.090
 Why?
Quality Assurance, Health Care
1
2013
314
0.090
 Why?
Retrospective Studies
5
2025
16755
0.080
 Why?
Follow-Up Studies
2
2024
5317
0.080
 Why?
Emergency Service, Hospital
1
2022
2266
0.080
 Why?
Hospitals
1
2014
695
0.080
 Why?
Diabetes Mellitus, Type 2
1
2022
2590
0.070
 Why?
Reverse Transcriptase Inhibitors
1
2007
87
0.070
 Why?
Chronic Disease
1
2013
1826
0.060
 Why?
Drug Resistance, Viral
1
2007
119
0.060
 Why?
Patient Care Team
1
2012
676
0.060
 Why?
Taxes
1
2026
16
0.060
 Why?
Anti-Retroviral Agents
1
2008
240
0.060
 Why?
Renal Insufficiency
1
2008
167
0.060
 Why?
Behavioral Risk Factor Surveillance System
1
2025
58
0.060
 Why?
Risk Factors
2
2014
10623
0.060
 Why?
Insurance, Health
2
2005
296
0.060
 Why?
Regression Analysis
2
2005
1003
0.060
 Why?
Aged, 80 and over
4
2024
8130
0.060
 Why?
Naltrexone
1
2025
117
0.050
 Why?
Insurance Coverage
2
2022
236
0.050
 Why?
Vaccination
2
2022
1414
0.050
 Why?
Pregnancy Complications, Infectious
1
2008
420
0.050
 Why?
Drug Therapy, Combination
2
2022
1032
0.050
 Why?
Quality Improvement
1
2012
1268
0.050
 Why?
Housing
1
2024
145
0.050
 Why?
Social Networking
1
2023
36
0.050
 Why?
Mobile Health Units
1
2022
20
0.050
 Why?
Rural Health Services
1
2004
140
0.050
 Why?
Midwestern United States
1
2002
44
0.050
 Why?
Health Services for the Aged
1
2003
72
0.050
 Why?
Pragmatic Clinical Trials as Topic
1
2022
133
0.050
 Why?
Health Status
2
2005
821
0.050
 Why?
Hospitals, University
1
2002
175
0.050
 Why?
Bupropion
1
2022
44
0.040
 Why?
Stakeholder Participation
1
2022
83
0.040
 Why?
Antiviral Agents
1
2007
743
0.040
 Why?
Schools, Medical
1
2023
158
0.040
 Why?
Continuity of Patient Care
1
2004
286
0.040
 Why?
Quality of Life
2
2022
3141
0.040
 Why?
Meals
1
2022
132
0.040
 Why?
England
1
2021
109
0.040
 Why?
Vulnerable Populations
1
2022
172
0.040
 Why?
HIV
1
2022
248
0.040
 Why?
Data Collection
1
2024
636
0.040
 Why?
Hospital Mortality
1
2025
975
0.040
 Why?
Minority Groups
1
2022
280
0.040
 Why?
Poverty
1
2024
522
0.040
 Why?
Length of Stay
1
2025
1312
0.040
 Why?
Urban Population
1
2003
485
0.040
 Why?
Triage
1
2021
247
0.040
 Why?
Medicaid
1
2003
455
0.040
 Why?
Age Factors
1
2026
3288
0.040
 Why?
Learning
1
2023
447
0.040
 Why?
Zambia
2
2008
56
0.030
 Why?
Treatment Outcome
1
2012
11459
0.030
 Why?
Medicare
1
2003
821
0.030
 Why?
Practice Guidelines as Topic
1
2025
1525
0.030
 Why?
Emtricitabine
2
2008
205
0.030
 Why?
Tenofovir
2
2008
293
0.030
 Why?
Curriculum
1
2023
1044
0.030
 Why?
Child
2
2024
22441
0.020
 Why?
Case-Control Studies
1
2017
3614
0.020
 Why?
Socioeconomic Factors
2
2004
1327
0.020
 Why?
Chi-Square Distribution
1
2008
516
0.020
 Why?
Antiretroviral Therapy, Highly Active
1
2008
277
0.020
 Why?
Creatinine
1
2008
492
0.020
 Why?
Risk
1
2008
901
0.010
 Why?
Proportional Hazards Models
1
2008
1305
0.010
 Why?
Pregnancy
2
2008
7154
0.010
 Why?
Glomerular Filtration Rate
1
2008
751
0.010
 Why?
Health Status Indicators
1
2004
162
0.010
 Why?
Office Visits
1
2003
91
0.010
 Why?
Health Care Surveys
1
2003
535
0.010
 Why?
Disease Progression
1
2008
2871
0.010
 Why?
Biomarkers
1
2008
4248
0.010
 Why?
Infant, Newborn
1
2007
6362
0.010
 Why?
Kruse's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (245) concept(s)
_
Co-Authors Expand Description
See all (18) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)